Why the study?
Does carvedilol inhibit PDGF-induced signal transduction and mitogenesis in human cardiac fibroblasts?
Population
Human cardiac fibroblasts cultured from myocardial biopsy samples taken from patients with idiopathic…
Comparison
Carvedilol (1, 5, 10, and 20 microM) vs Other beta-adrenoceptor antagonists and PDGF…
Design
Preclinical
Authors
Loading...
Carvedilol may inhibit fibroblast mitogenesis via PDGF; leaves open any clinical anti-fibrotic role in heart failure.
Does carvedilol inhibit PDGF-induced signal transduction and mitogenesis in human cardiac fibroblasts?
Carvedilol inhibits PDGF-stimulated mitogenesis and receptor autophosphorylation in human cardiac fibroblasts, providing a potential mechanism for its anti-fibrotic effects in chronic heart failure.
Lotze et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: